DEFINITION of 'Bioequivalence'

Bioequivalence is the similarity of two drugs that share the same desired outcome for patients. Pharmaceutical equivalence means two drugs release the active ingredient into the bloodstream at the same amount and same rate. When assessing how well a generic drug works, scientists evaluate its bioequivalence to the name-brand version.

BREAKING DOWN 'Bioequivalence'

Bioequivalence is determined by pharmacokinetic studies to determine whether a commercially available brand product and a potential to market generic version share core attributes. For a generic drug manufacturer to get the U.S. Food and Drug Administration’s (FDA) stamp of approval, they must prove it is pharmaceutically equal to the name-brand version. A drug maker must also get FDA approval before marketing or selling a different version of an approved drug. For example, it must prove a once-a-week tablet is bioequivalent to a daily tablet.

In addition, the FDA has different bioequivalence standards depending on whether the drug is taken as a pill, injection, patch, inhaler or through another method. When a generic drug is not bioequivalent to the name-brand version, it might still be approved for another use, but not be approved as a substitute for the name-brand version.

Unlike their name-brand counterparts, generic drugs usually don’t need to go through the full clinical trial process to get approved because generic drugs only have to be bioequivalent. The company applying for approval to market the generic drug must only test the generic drug against the brand-name drug on two small groups of test subjects, draw timed blood samples from each patient, and show through statistical analysis that any difference in the drug’s bioavailability in participants taking the brand name version versus participants taking the generic version is not clinically significant.

It is easier to make a bioequivalent form of a traditional pill or injectable drug than to make a bioequivalent form of a biologic drug. As a result, the generic versions of biologic drugs, called “biosimilars,” may have to undergo clinical trials to gain approval.

"Bioequivalence" Issues

While bioequivalent drugs offer patients many benefits, some concerns still remain. Bioequivalence problems have been reported by physicians and patients that many approved generic drugs do not have the same desired impact as the branded counterparts. Certain classes are more prone to these discrepancies from specific chemical reactions. Some of these include poorly absorbed drugs, chiral drugs and other complex delivery mechanisms. Physicians are cautious in switching patients from branded to generic products, or between different generic manufacturers when prescribing ant-epileptic drugs and blood thinners.

RELATED TERMS
  1. Abbreviated New Drug Submission ...

    An Abbreviated New Drug Submission (ANDS) is a written request ...
  2. Drug

    A drug is a substance that cures, treats, prevents or reduces ...
  3. Generic Brand

    A generic brand is a type of consumer product that lacks a widely ...
  4. New Drug

    New drug is an original or innovative medication or therapy that ...
  5. New Indications

    New indications is a term used by medical companies and professionals ...
  6. Food And Drug Administration (FDA)

    The Food and Drug Administration is a government agency that ...
Related Articles
  1. Investing

    Market Vectors Launches First Generic Drugs ETF (GNRX)

    Generic drugs have been a growing market in recent years. Now there is an ETF targeted at this market.
  2. Investing

    Cost of Old Cancer Drugs Rises in EU Amid Outcry

    The prices of several off-patent cancer drugs have soared more than 100% in Europe.
  3. Investing

    Pharma Balks at German Price Control (BAYRY, RHHBY)

    Drug makers are worried about a proposed new German law that would tighten price controls on prescription drugs.
  4. Investing

    Using DCF In Biotech Valuation

    Valuing firms in this sector can seem like a black art, but there is a systematic way to pin a price on potential.
  5. Investing

    Where Does the US Get Its Supply of Drugs?

    Despite increasing demands for local production, the US imports only a small portion of its drugs.
  6. Investing

    Samsung Wants to Become a Drug Company

    Samsung is expanding its drug efforts, inking a deal to create drugs for hard-to-treat diseases.
  7. Personal Finance

    Supplemental Indications: The Promising Pharma Stream (GILD)

    While supplemental indications can lead to more revenues and wider treatment options, they may add substantially to the drug cost for the end patients.
  8. Insights

    Why Drug Prices Keep Rising & How to Fight Back

    Despite pushback from politicians and disgruntled consumers, the cost of drugs keeps going up. Is there any relief on the horizon?
  9. Investing

    Evaluating Pharmaceutical Companies

    Learn how to find a healthy pharmaceutical investment in a market full of weak drugs.
  10. Investing

    3 of America's Most Expensive Drugs and Who Profits From Them

    Learn about orphan drugs that are some of the most expensive drugs in America. Read about the companies that manufacture these drugs.
RELATED FAQS
  1. Do financial advisors get drug tested?

    Financial advisor regulatory bodies do not require drug testing, but many individual firms that hire advisors do. Read Answer >>
  2. Who are Pfizer's (PFE) main competitors?

    Learn about Pfizer's place in the pharmaceutical industry, and find out which major drug manufacturers are among its main ... Read Answer >>
  3. Biotech vs Pharmaceutical company

    Though biotech and pharmaceutical companies share similar business features, there also have differences. Here, we'll distinguish ... Read Answer >>
  4. How can I use zero-based budgeting for my own finances?

    Learn the difference between a copay and a deductible, two very common features of most health insurance plans in the United ... Read Answer >>
  5. How does operating leverage affect business risk?

    Learn how operating leverage affects business risk and how companies measure it. Review a relevant example of operating leverage ... Read Answer >>
Trading Center